Raiffeisen Bank International’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84M Buy
6,451
+2,810
+77% +$924K 0.03% 307
2025
Q4
$1.27M Sell
3,641
-157
-4% -$53.1K 0.02% 310
2025
Q3
$1.21M Buy
3,798
+1,971
+108% +$613K 0.02% 309
2025
Q2
$683K Sell
1,827
-427
-19% -$172K 0.01% 326
2025
Q1
$974K Sell
2,254
-1,028
-31% -$413K 0.02% 286
2024
Q4
$1.21M Buy
+3,282
New +$1.37M 0.02% 255

Other funds holding ELV

Raiffeisen Bank International's ELV Position: Q1 2026 in Review

Raiffeisen Bank International increased its Elevance Health (ELV) stake by 77% in Q1 2026, buying an estimated $924K and bringing the position to 6,451 shares worth $1.84M. The position accounts for 0.03% of the portfolio, ranked #307.

Raiffeisen Bank International first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Raiffeisen Bank International held 6,451 shares of Elevance Health worth $1.84M as of Q1 2026.
  • Raiffeisen Bank International bought 2,810 Elevance Health shares in Q1 2026, an estimated $924K.
  • Elevance Health made up 0.03% of Raiffeisen Bank International's portfolio in Q1 2026, its #307 holding.
  • Raiffeisen Bank International first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.